Nanosonics Ltd
NAN: XASX (AUS)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|@#%gQr | LOCK|#GL?X | LOCK|BGmNh^? |
Nanosonics Earnings: Shares Undervalued Despite Currency Headwinds as Margins Expand
Nanosonics' interim 2026 constant-currency EBIT grew 15% on 8% sales growth and margin uplift. While gross margin fell 230 basis points on sales mix, operating expenses grew just 4% on lower research and development costs. Constant-currency guidance ranges were reaffirmed. Shares fell 10%.
